Annual EBITDA
$232.87 M
-$22.03 M-8.64%
December 31, 2023
Summary
- As of February 7, 2025, PACS annual EBITDA is $232.87 million, with the most recent change of -$22.03 million (-8.64%) on December 31, 2023.
- During the last 3 years, PACS annual EBITDA has risen by +$139.01 million (+148.11%).
- PACS annual EBITDA is now -8.64% below its all-time high of $254.89 million, reached on December 31, 2022.
Performance
PACS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$5.58 M
-$90.77 M-94.21%
June 30, 2024
Summary
- As of February 7, 2025, PACS quarterly EBITDA is $5.58 million, with the most recent change of -$90.77 million (-94.21%) on June 30, 2024.
- Over the past year, PACS quarterly EBITDA has dropped by -$47.47 million (-89.48%).
- PACS quarterly EBITDA is now -94.21% below its all-time high of $96.35 million, reached on March 31, 2024.
Performance
PACS Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
$101.93 M
-$47.47 M-31.78%
June 30, 2024
Summary
- As of February 7, 2025, PACS TTM EBITDA is $101.93 million, with the most recent change of -$47.47 million (-31.78%) on June 30, 2024.
- Over the past year, PACS TTM EBITDA has dropped by -$16.69 million (-14.07%).
- PACS TTM EBITDA is now -31.78% below its all-time high of $149.40 million, reached on March 31, 2024.
Performance
PACS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
PACS EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -8.6% | -89.5% | -14.1% |
| 3 y3 years | +148.1% | -89.5% | -14.1% |
| 5 y5 years | +148.1% | -89.5% | -14.1% |
PACS EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -8.6% | +148.1% | -94.2% | at low | -31.8% | +55.5% |
| 5 y | 5-year | -8.6% | +148.1% | -94.2% | at low | -31.8% | +55.5% |
| alltime | all time | -8.6% | +148.1% | -94.2% | at low | -31.8% | +55.5% |
PACS EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2024 | - | $5.58 M(-94.2%) | $101.93 M(-31.8%) |
| Mar 2024 | - | $96.35 M(+81.6%) | $149.40 M(+26.0%) |
| Dec 2023 | $232.87 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | $53.05 M(-19.1%) | $118.62 M(+80.9%) |
| Mar 2023 | - | $65.56 M | $65.56 M |
| Dec 2022 | $254.89 M(+171.6%) | - | - |
| Dec 2021 | $93.86 M | - | - |
FAQ
- What is PACS annual EBITDA?
- What is the all time high annual EBITDA for PACS?
- What is PACS annual EBITDA year-on-year change?
- What is PACS quarterly EBITDA?
- What is the all time high quarterly EBITDA for PACS?
- What is PACS quarterly EBITDA year-on-year change?
- What is PACS TTM EBITDA?
- What is the all time high TTM EBITDA for PACS?
- What is PACS TTM EBITDA year-on-year change?
What is PACS annual EBITDA?
The current annual EBITDA of PACS is $232.87 M
What is the all time high annual EBITDA for PACS?
PACS all-time high annual EBITDA is $254.89 M
What is PACS annual EBITDA year-on-year change?
Over the past year, PACS annual EBITDA has changed by -$22.03 M (-8.64%)
What is PACS quarterly EBITDA?
The current quarterly EBITDA of PACS is $5.58 M
What is the all time high quarterly EBITDA for PACS?
PACS all-time high quarterly EBITDA is $96.35 M
What is PACS quarterly EBITDA year-on-year change?
Over the past year, PACS quarterly EBITDA has changed by -$47.47 M (-89.48%)
What is PACS TTM EBITDA?
The current TTM EBITDA of PACS is $101.93 M
What is the all time high TTM EBITDA for PACS?
PACS all-time high TTM EBITDA is $149.40 M
What is PACS TTM EBITDA year-on-year change?
Over the past year, PACS TTM EBITDA has changed by -$16.69 M (-14.07%)